- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Coelenterazine 400a |
| Catalog No. | RESK-0269 |
| Description | Coelenterazine 400a is a derivative of native coelenterazine and a good substrate for Renilla luciferase (Rluc), but it is not oxidized by Gaussia luciferase (Gluc). Its maximum emission wavelength is around 400 nm, causing minimal signal interference with GFP acceptor proteins, which makes it an important coelenterazine-class substrate for BRET (bioluminescence resonance energy transfer) studies. |
| Intended Use | Bioluminescent substrate for Renilla luciferase (Rluc) in BRET studies, in vivo imaging, in vitro reporter gene assays, microbial/viral monitoring, and pyrophosphate sequencing. |
| Principle / Technology | Luciferase-catalyzed oxidation of the coelenterazine derivative in the presence of molecular oxygen produces blue light with a maximum emission around 400 nm, well separated from GFP acceptor emission. |
| Detection Method | Bioluminescence detection (luminometer, scintillation counter, or small-animal in vivo imaging system with a bioluminescence module); maximum emission ~400 nm |
| Sample Type | Rluc-expressing cells, tissues, and research animals; in vitro assay systems |
| Performance Range / Specifications | Synonym: Di-dehydro Coelenterazine CAS No.: 70217-82-2 Molecular formula: C26H21N3O Molecular weight: 391.48 g/mol Appearance: Yellow to orange powder Purity (TLC): >98% Solubility: Soluble in methanol and ethanol; insoluble in DMSO. Emission maximum: ~400 nm. |
| Specificity | Good substrate for Renilla luciferase (Rluc); not oxidized by Gaussia luciferase (Gluc); minimal signal interference with GFP acceptor proteins. |
| Reaction Conditions / Protocol | Administration routes for in vivo imaging: intraperitoneal injection gives slower diffusion, slower onset of luminescence, and longer-lasting signal; tail vein injection gives fast diffusion, rapid onset, and shorter signal duration. Detection timing: in vitro, detect immediately after 10-15 min of cell incubation; in vivo, detect within 10-15 min after injection. For reference only: establish the luciferase kinetic curve in a preliminary experiment to determine the peak signal time and signal plateau. |
| Storage Conditions | Store the powder at -20 °C, dry and protected from light; preferably under an inert gas atmosphere, avoiding contact with air. |
| Shelf Life | 1 year. |
| Package Specifications | 1 x 500 ug 2 x 500 ug |
| Product Form | Yellow to orange powder |
| Purity | >98% (TLC) |
| Molecular Weight | 391.48 g/mol |
| Shipping Conditions | Shipped with ice packs. |
| Recommended Buffer System | Water or PBS without calcium and magnesium ions for dilution; Mg2+ is important for firefly luciferin substrate oxidation, while Ca2+ is the ion relevant to coelenterazine substrate oxidation. |
| Application Notes / Precautions | 1. Protect from light and air; storage under inert gas is recommended. 2. Insoluble in DMSO; use methanol or ethanol as solvent. 3. Detection requires an instrument with a bioluminescence/chemiluminescence module (e.g., a small-animal in vivo imaging system); for multi-mode microplate readers, confirm with the manufacturer that a luminescence detection module is installed. Fluorescence microscopes cannot be used. 4. Suitable for BRET studies due to its ~400 nm emission with minimal interference on GFP acceptor signals. |
For research use only, not for clinical use.
|
There is no product in your cart. |